|
|
Blood, 15 March 2004, Vol. 103, No. 6, pp. 1985-1994.
Prepublished online as a Blood First Edition Paper on November 20, 2003October 30, 2003; DOI 10.1182/blood-2003-06-2126.

Submitted June 27, 2003
Accepted October 19, 2003
Overexpression of IL-7R provides a competitive advantage during early T-cell development
Yasmina Laouar, I Nicholas Crispe, and Richard A Flavell*
Section of Immunobiology, Yale University School of Medicine, New Haven, CT, USA; Howard Hughes Medical Institute, New Haven, CT, USA
David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA
* Corresponding author; email: richard.flavell{at}yale.edu.
Critical checkpoints controlling early thymic T-cell development and homeostasis are set by the proper signaling function of the IL-7 receptor (IL-7R) and the pre-T cell antigen receptor. Although  T-cell development is observed in IL-7- and IL-7R -deficient mice, the number of thymocytes is significantly reduced, implying a role for the IL-7R in controlling the size of the thymic T cell compartment. Here, we report the over-expression of IL-7R in the early T-cell compartment from AKR/J mice, which are highly susceptible to the spontaneous development of thymoma. Increased IL-7R was revealed by surface staining, and increased IL-7R mRNA was documented using RT-PCR. This resulted in increased survival of AKR/J early thymocytes, shown by the decreased frequency of TUNEL+ cells. In an in vivo thymocyte repopulation model, AKR/J thymocytes had a selective advantage over normal B10.BR thymocytes. This advantage occurred at early stages of T cell development. Our findings support the model that overexpression of growth factor receptors can contribute to proliferation and malignancy.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Can increased cytokine receptor signaling cause leukemia?
- Kenneth Weinberg
Blood 2004 103: 1976-1977.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
S. Gonzalez-Garcia, M. Garcia-Peydro, E. Martin-Gayo, E. Ballestar, M. Esteller, R. Bornstein, J. L. de la Pompa, A. A. Ferrando, and M. L. Toribio
CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia
J. Exp. Med.,
April 13, 2009;
206(4):
779 - 791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yang, B. Madison, D. L. Gumucio, and D. H. Teitelbaum
Specific overexpression of IL-7 in the intestinal mucosa: the role in intestinal intraepithelial lymphocyte development
Am J Physiol Gastrointest Liver Physiol,
June 1, 2008;
294(6):
G1421 - G1430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Munitic, J. A. Williams, Y. Yang, B. Dong, P. J. Lucas, N. El Kassar, R. E. Gress, and J. D. Ashwell
Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis
Blood,
December 15, 2004;
104(13):
4165 - 4172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Barata, A. Silva, J. G. Brandao, L. M. Nadler, A. A. Cardoso, and V. A. Boussiotis
Activation of PI3K Is Indispensable for Interleukin 7-mediated Viability, Proliferation, Glucose Use, and Growth of T Cell Acute Lymphoblastic Leukemia Cells
J. Exp. Med.,
September 7, 2004;
200(5):
659 - 669.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|